ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

MSKCC hopes to raise $1 billion in five-year campaign.

November 7, 2003

Guest Editorial: FDA Must Address Economic Incentives to Resolve Drug Shortages Permanently

February 24, 2012

Sandra Swain Elected ASCO President for 2012

December 10, 2010

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

Walter Curran Succeeds Brian Leyland-Jones As Director Of Emory’s Cancer Center

September 25, 2009

ASCO To Open Abstracts To Everyone Prior To Annual Meeting.

November 16, 2007